OrthoPediatrics Corp. KIDS · Stock Open OrthoPediatrics Corp. in new tab
OrthoPediatrics Corp. Analysis (KIDS)
Is OrthoPediatrics Corp. a good investment? OrthoPediatrics Corp. (KIDS) is currently trading at 20.87 USD. Market analysts have a consensus price target of 25.00 USD. This suggests a potential upside from current levels.
Earnings Schedule: OrthoPediatrics Corp. is expected to release its next earnings report on Aug. 4, 2026. The market consensus estimate for Forward EPS is -0.68.
Investor FAQ
Does OrthoPediatrics Corp. pay a dividend?
No, it does not currently pay a dividend.
What asset class is OrthoPediatrics Corp.?
OrthoPediatrics Corp. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Aug. 4, 2026. The company currently has a trailing EPS of -1.68.
Company Profile
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, Mitchell Ponseti, VerteGlideTM, and Boston Brace 3D. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
Community Discussion